Excerpted from the March 23, 2016 blog post:
The Online Partnership to Accelerate Research (OnPAR) program, operated by Leidos Life Sciences, will act as a matchmaker between unfunded NIH applicants and private research funders. OnPAR’s growing list of private funders currently includes the Juvenile Diabetes Research Foundation, National Alopecia Areata Foundation, Children’s Tumor Foundation, Adenoid Cystic Carcinoma Research Foundation, Breast Cancer Research Foundation, Melanoma Research Alliance, and Parent Project Muscular Dystrophy. We anticipate that more private funders and federal research agencies will be added to this program in the future.More information is available in a March 23 Science Translational Medicine article, Funding unfunded NIH research application.
To begin the process, NIH program officers will inform select applicants about potential funding opportunities via the OnPAR pilot. Select applicants include those who have a) have undergone Council review within the past year, b) have scored well (i.e., within the 30th percentile or promising non-percentiled applications), c) were unfunded and d) have research proposals that fall under the missions of the participating private funders. Applicants, at their discretion, can decide whether to submit materials to OnPAR for consideration of private funding.